Cargando…

Type I Angiotensin II Receptor Blockade Reduces Uremia‐Induced Deterioration of Bone Material Properties

Chronic kidney disease (CKD) is associated with a high incidence of fractures. However, the pathophysiology of this disease is not fully understood, and limited therapeutic interventions are available. This study aimed to determine the impact of type 1 angiotensin II receptor blockade (AT‐1RB) on pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakamatsu, Takuya, Iwasaki, Yoshiko, Yamamoto, Suguru, Matsuo, Koji, Goto, Shin, Narita, Ichiei, Kazama, Junichiro J, Tanaka, Kennichi, Ito, Akemi, Ozasa, Ryosuke, Nakano, Takayoshi, Miyakoshi, Chisato, Onishi, Yoshihiro, Fukuma, Shingo, Fukuhara, Shunichi, Yamato, Hideyuki, Fukagawa, Masafumi, Akizawa, Tadao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328427/ https://www.ncbi.nlm.nih.gov/pubmed/32786093 http://dx.doi.org/10.1002/jbmr.4159

Ejemplares similares

Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients
por: Yamamoto, Suguru, et al.
Publicado: (2015)

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism
por: Kato, Chihiro, et al.
Publicado: (2020)

Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study
por: Asada, Shinji, et al.
Publicado: (2020)

Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan
por: Fukuma, Shingo, et al.
Publicado: (2013)

Population-level associations of achievement of targets for bone-mineral markers with survival in haemodialysis patients with mildly elevated intact-PTH levels: a case-cohort study
por: Fukuma, Shingo, et al.
Publicado: (2019)

Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy
por: Yokoyama, Keitaro, et al.
Publicado: (2017)

Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study
por: Kurita, Noriaki, et al.
Publicado: (2015)

Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study
por: Asada, Shinji, et al.
Publicado: (2019)

Impact of nutritional index on the association between phosphorus concentrations and mortality in haemodialysis patients: a cohort study from dialysis outcomes and practice pattern study in Japan
por: Fukuma, Shingo, et al.
Publicado: (2017)

Association of coping strategies with mortality and health-related quality of life in hemodialysis patients: The Japan Dialysis Outcomes and Practice Patterns Study
por: Niihata, Kakuya, et al.
Publicado: (2017)

Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study
por: Tanaka, Motoko, et al.
Publicado: (2016)

The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study
por: Ogata, Hiroaki, et al.
Publicado: (2017)

Length of hospital stay is associated with a decline in activities of daily living in hemodialysis patients: a prospective cohort study
por: Kamitani, Tsukasa, et al.
Publicado: (2020)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Development and validation of a prediction model for loss of physical function in elderly hemodialysis patients
por: Fukuma, Shingo, et al.
Publicado: (2018)

Dialysis‐related practice patterns among hemodialysis patients with cancer
por: Nishiwaki, Hiroki, et al.
Publicado: (2018)

Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation
por: Shoji, Tetsuo, et al.
Publicado: (2016)

Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate
por: Matsuo, Koji, et al.
Publicado: (2015)

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties
por: Kazama, Junichiro James, et al.
Publicado: (2022)

Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese dialysis outcomes and practice pattern study (J-DOPPS)
por: Kido, Ryo, et al.
Publicado: (2019)

Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated
por: Wakamatsu, Takuya, et al.
Publicado: (2018)

Self-reported Slower Eating Is Associated with a Lower Salt Intake: A Population-based Cross-sectional Study
por: Wakasugi, Minako, et al.
Publicado: (2018)

Understanding Measurements of Vitality in Patients with Chronic Kidney Disease: Connecting a Quality-of-Life Scale to Daily Activities
por: Fukuhara, Shunichi, et al.
Publicado: (2012)

Dialysis physicians’ referral behaviors for hemodialysis patients suspected of having cancer: A vignette-based questionnaire study
por: Fukuma, Shingo, et al.
Publicado: (2018)

Uremic osteoporosis
por: Kazama, Junichiro J, et al.
Publicado: (2013)

Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease
por: Iwasaki, Yoshiko, et al.
Publicado: (2017)

Control of severe hyperparathyroidism in dialysis patients with nodular hyperplasia
por: Fukagawa, Masafumi, et al.
Publicado: (2008)

Uremia
por: Low, J. H.
Publicado: (1883)

Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy
por: Koda, Ryo, et al.
Publicado: (2014)

Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events
por: Hara, Takashi, et al.
Publicado: (2020)

Interdialytic Weight Gain Effects on Hemoglobin Concentration and Cardiovascular Events
por: Hara, Takashi, et al.
Publicado: (2021)

Monocytes in Uremia
por: Girndt, Matthias, et al.
Publicado: (2020)

Experimental Uremia
Publicado: (1882)

Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study
por: Akizawa, Tadao, et al.
Publicado: (2018)

Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS)
por: Matsubara, Yukiko, et al.
Publicado: (2017)

Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism
por: Sato, Tetsuhiko, et al.
Publicado: (2019)

α-Blocker Use in Hemodialysis: The Japan Dialysis Outcomes and Practice Patterns Study
por: Iseri, Ken, et al.
Publicado: (2023)

The Treatment of Reversible Uremia
por: Epstein, Franklin H.
Publicado: (1954)

Benzoate of Sodium in Uremia
Publicado: (1888)

Uremia with War Wounded
Publicado: (1919)

Cannot write session to /tmp/vufind_sessions/sess_k5fftctua02l8rcouissjkkrm7